196 related articles for article (PubMed ID: 29751008)
21. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
22. Glycosylation of Fcγ receptors influences their interaction with various IgG1 glycoforms.
Cambay F; Forest-Nault C; Dumoulin L; Seguin A; Henry O; Durocher Y; De Crescenzo G
Mol Immunol; 2020 May; 121():144-158. PubMed ID: 32222585
[TBL] [Abstract][Full Text] [Related]
23. Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry.
Ghirlando R; Lund J; Goodall M; Jefferis R
Immunol Lett; 1999 May; 68(1):47-52. PubMed ID: 10397155
[TBL] [Abstract][Full Text] [Related]
24. Glycoform-resolved FcɣRIIIa affinity chromatography-mass spectrometry.
Lippold S; Nicolardi S; Domínguez-Vega E; Heidenreich AK; Vidarsson G; Reusch D; Haberger M; Wuhrer M; Falck D
MAbs; 2019 Oct; 11(7):1191-1196. PubMed ID: 31276431
[TBL] [Abstract][Full Text] [Related]
25. Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan.
Falconer DJ; Subedi GP; Marcella AM; Barb AW
ACS Chem Biol; 2018 Aug; 13(8):2179-2189. PubMed ID: 30016589
[TBL] [Abstract][Full Text] [Related]
26. Impact of Fc N-glycan sialylation on IgG structure.
Zhang Z; Shah B; Richardson J
MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
[TBL] [Abstract][Full Text] [Related]
27. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc
Sénard T; Gargano AFG; Falck D; de Taeye SW; Rispens T; Vidarsson G; Wuhrer M; Somsen GW; Domínguez-Vega E
Front Immunol; 2020; 11():2049. PubMed ID: 32973813
[TBL] [Abstract][Full Text] [Related]
28. Recognition of Human IgG1 by Fcγ Receptors: Structural Insights from Hydrogen-Deuterium Exchange and Fast Photochemical Oxidation of Proteins Coupled with Mass Spectrometry.
Shi L; Liu T; Gross ML; Huang Y
Biochemistry; 2019 Feb; 58(8):1074-1080. PubMed ID: 30666863
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the correlation between charge and glycosylation of IgG1 variants by liquid chromatography-mass spectrometry.
Yang JM; Ai J; Bao Y; Yuan Z; Qin Y; Xie YW; Tao D; Fu D; Peng Y
Anal Biochem; 2014 Mar; 448():82-91. PubMed ID: 24287081
[TBL] [Abstract][Full Text] [Related]
30. Structure of the murine unglycosylated IgG1 Fc fragment.
Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
[TBL] [Abstract][Full Text] [Related]
31. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.
Mimura Y; Church S; Ghirlando R; Ashton PR; Dong S; Goodall M; Lund J; Jefferis R
Mol Immunol; 2000; 37(12-13):697-706. PubMed ID: 11275255
[TBL] [Abstract][Full Text] [Related]
32. Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody.
Falck D; Thomann M; Lechmann M; Koeleman CAM; Malik S; Jany C; Wuhrer M; Reusch D
MAbs; 2021; 13(1):1865596. PubMed ID: 33382957
[TBL] [Abstract][Full Text] [Related]
33. Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry.
Houde D; Arndt J; Domeier W; Berkowitz S; Engen JR
Anal Chem; 2009 Apr; 81(7):2644-51. PubMed ID: 19265386
[TBL] [Abstract][Full Text] [Related]
34. Mouse milk immunoglobulin G Fc-linked N-glycosylation nano-LC-MS analysis in a model of vancomycin exposure during pregnancy.
Alhasan MM; Habazin S; Kahhaleh FG; Lauc G; Conrad ML; Novokmet M
Anal Bioanal Chem; 2023 May; 415(12):2239-2247. PubMed ID: 36914840
[TBL] [Abstract][Full Text] [Related]
35. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
[TBL] [Abstract][Full Text] [Related]
36. Biosimilarity Assessments of Model IgG1-Fc Glycoforms Using a Machine Learning Approach.
Kim JH; Joshi SB; Tolbert TJ; Middaugh CR; Volkin DB; Smalter Hall A
J Pharm Sci; 2016 Feb; 105(2):602-612. PubMed ID: 26869422
[TBL] [Abstract][Full Text] [Related]
37. Glycoengineering of human IgG1-Fc through combined yeast expression and in vitro chemoenzymatic glycosylation.
Wei Y; Li C; Huang W; Li B; Strome S; Wang LX
Biochemistry; 2008 Sep; 47(39):10294-304. PubMed ID: 18771295
[TBL] [Abstract][Full Text] [Related]
38. Revisiting the role of glycosylation in the structure of human IgG Fc.
Borrok MJ; Jung ST; Kang TH; Monzingo AF; Georgiou G
ACS Chem Biol; 2012 Sep; 7(9):1596-602. PubMed ID: 22747430
[TBL] [Abstract][Full Text] [Related]
39. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
[TBL] [Abstract][Full Text] [Related]
40. High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples.
Reusch D; Haberger M; Selman MH; Bulau P; Deelder AM; Wuhrer M; Engler N
Anal Biochem; 2013 Jan; 432(2):82-9. PubMed ID: 23026777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
